FY2029 Earnings Estimate for Kura Oncology Issued By Wedbush
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Stock analysts at Wedbush issued their FY2029 earnings estimates for Kura Oncology in a note issued to investors on Thursday, February 6th. Wedbush analyst R. Driscoll expects that the company will post earnings of $2.60 per share for the year. Wedbush has a “Outperform” rating and a […]
![FY2029 Earnings Estimate for Kura Oncology Issued By Wedbush](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/kura-oncology-inc-logo-1200x675.jpg?v=20240515093805&w=240&h=240&zc=2)